HTH
Hilltop Holdings Inc.
HTH offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has the edge over HTH overall, supported by stronger fundamentals and stronger modeled upside.
HTH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
HTH's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HTH.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
HTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.5x | $15.72 | -56% |
| Fair | 14x | $34.01 | -5.8% |
| Current | 15x | $36.10 | — |
| Forward | 16x | $36.10 | — |
| Expensive | 18x | $43.63 | +21% |
Historical ranges are pointers, not guarantees.
HTH's PE is in its fair range at 15x. On analysts' estimates for next year's earnings, today's price would be 16x, in its expensive range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over HTH in the historical PE scenario, which offers more potential upside but is not a forecast.
HTH Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect HTH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over HTH on the outlook, with more favorable valuation and revenue expectations.
HTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.23 | -7% |
| Q3 2026 | $2.40 | -4.4% |
| Q2 2026 | $2.70 | +21% |
| Q1 2026 | $2.64 | +34% |
| Q4 2025 | $2.65 | +52% |
| Q3 2025 | $2.51 | +54% |
| Q2 2025 | $2.23 | +28% |
| Q1 2025 | $1.97 | +15% |
| Q4 2024 | $1.74 | +3% |
HTH's earnings per share have fallen from their peak: $2.40 over the past year, against $5.93 in early 2021.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
HTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $309.5M | -6.3% |
| Q2 2026 | $315.8M | +4.1% |
| Q1 2026 | $300.5M | -5.6% |
| Q4 2025 | $329.9M | +9.6% |
| Q3 2025 | $330.2M | +8.1% |
| Q2 2025 | $303.3M | +2.1% |
| Q1 2025 | $318.5M | +12% |
| Q4 2024 | $301.1M | +3.7% |
HTH's revenue fell from its 2020 peak and has held roughly level since: $310M last quarter, down 6.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -7 points |
| Q2 2026 | 16% | -0.5 points |
| Q1 2026 | 17% | -1.3 points |
| Q4 2025 | 16% | +1.4 points |
| Q3 2025 | 18% | +4.5 points |
| Q2 2025 | 16% | +6.4 points |
| Q1 2025 | 18% | +4.8 points |
| Q4 2024 | 15% | +1.5 points |
HTH's operating margin was 11% last quarter, down 7 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over HTH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over HTH on profitability, with a higher operating margin.
HTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $503.6M | +86% |
| Q2 2026 | -$162.8M | +$71.7M |
| Q1 2026 | -$133.9M | -2757% |
| Q4 2025 | -$97M | -180% |
| Q3 2025 | $271M | -47% |
| Q2 2025 | -$234.6M | +$202.7M |
| Q1 2025 | $5M | -93% |
| Q4 2024 | $121.9M | -53% |
HTH has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
HTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | -2.6x | Net Cash |
| Q2 2025 | -1.2x | Net Cash |
| Q1 2025 | -5.2x | Net Cash |
| Q4 2024 | 4.6x | High |
HTH has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
HTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 22.6 | Neutral |
HTH's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
HTH PE vs Financial Services Sector
| Metric | HTH | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 16% above |
| PE % | 61 | 63 | 2 pts below |
HTH is trading at 15x earnings, a 16% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over HTH on valuation relative to its sector.
HTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.0 | 2.5% below |
| 20 week MA | $38.2 | 5.4% below |
| 50 week MA | $37.3 | 3.2% below |
| 100 week MA | $34.2 | 5.5% above |
| 200 week MA | $32.7 | 10% above |
HTH has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 10% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over HTH on trend strength, trading above more of its moving averages.
HTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.6 | $27.3 | +11% |
| 2021 | $27.3 | $34.7 | +27% |
| 2022 | $34.7 | $29.7 | -14% |
| 2023 | $29.7 | $35.2 | +19% |
| 2024 | $35.2 | $28.9 | -18% |
| 2025 | $28.9 | $34.6 | +20% |
| 2026 YTD | $34.6 | $36.1 | +4.3% |
HTH has finished higher in four of the last six years. It's up 4.3% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over HTH on returns for 2026, with the stronger performance.